Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- DSW -18.3%, SIG -16.5%, TWMC -13.5%, CPB -6.9%, ZTO -6.5%, CHS -6.5%, BECN -4%, A -3.9%, TEDU -2.4%, BURL -2.4%, PDCO -2.4%, DAKT -1.9%, LOW -1.8%, CRH -1.3%, URBN -1%, INTU -0.8%
Other news:
- CYTK -29.7% (announces that VITALITY-ALS Phase 3 clinical trial of tirasemtiv in patients with amyotrophic lateral sclerosis did not meet the primary endpoint)
- PFGC -2.2% (prices 5 mln common stock offering by selling stockholder Wellspring Capital at $28.25/share)
- DGX -2.2% (Quest Diagnostics details impact of Medicare payment rates for clinical laboratory tests; expects impact to be approx 4% in 2018 and 10% 2019-2020; to host call tomorrow)
Analyst comments:
- TER -1.5% (downgraded to Hold at Deutsche Bank)